Avi Oler | SVP of Corporate Development and General Counsel |
Steve Fruchtman | President and CEO |
Mark Guerin | Chief Financial Officer |
Steve Cosenza | Lead Scientist |
Ladies and gentlemen, thank you for standing by. Welcome to the Onconova Therapeutics 2020 Financial Results and Business Update Conference call. At this time, all participants are in a listen-only mode.
Following management’s prepared remarks we will hold an question and answer session. [Operator Instructions] As a reminder, this call is being recorded today, March 11, 2021.